【11月3日IPO雷达】

Group 1 - The core viewpoint of the news is the introduction of new stock offerings, specifically focusing on Beikang Detection and Dana Biology, highlighting their market positions and financial metrics [1][2][3]. Group 2 - Beikang Detection has an issuance price of 6.70 yuan, a total market value of 569.2 million yuan, and an issuance price-earnings ratio of 14.99 [2]. - The company is a leading domestic inspection and testing service provider in the non-ferrous metal sector, participating in key national technology projects [2][3]. - The revenue composition shows that detection services account for 86.56%, inspection services for 8.62%, and instrument services for 4.82% [3]. - The company reported a net profit of 148 million yuan in the last three years, with a projected growth of 34.55% in 2024 [3]. Group 3 - Dana Biology has an issuance price of 17.10 yuan, a total market value of 810.4 million yuan, and an issuance price-earnings ratio of 11.75 [2]. - The company focuses on early diagnosis of invasive fungal diseases and has introduced a "5G + fungal disease serological joint detection scheme" to enhance diagnostic accuracy [2][3].